首页> 外文会议>Rapra International Conference on Blowing Agents and Foaming Processes >CLEAN AND EFFECTIVE CURING VITAL FOR ELASTOMER APPLICATIONS IN PHARMACEUTICAL PACKAGING
【24h】

CLEAN AND EFFECTIVE CURING VITAL FOR ELASTOMER APPLICATIONS IN PHARMACEUTICAL PACKAGING

机译:用于药物包装中弹性体应用的清洁有效的固化

获取原文

摘要

Due to their excellent elasticity, penetrability and resiliency performance, elastomers are being used in a wide range of pharmaceutical packaging. Historically the major use of elastomers in pharmaceutical packaging had transitioned from natural rubber in the early days to regular butyl (isobutylene isoprene rubber, IIR) and then chlorobutyl (CIIR) and bromobutyl (BUR) polymers. The main driver of these transitions is cleanliness improvements. With increasing awareness of the impacts of impurities in drugs on the health of patients, tighter and tighter regulations are being implemented. For example, in recent years the level of extractable and teachable components has become an important parameter for pharmaceutical stoppers to be qualified. The presence of certain impurities can also deactivate active ingredients or cause changes in certain medicines and therefore the drug compatibility of the stopper is important. Cleanliness of pharmaceutical stoppers is determined by the manufacturing process and the cleanliness of each ingredient in the compound, i.e., elastomers, fillers, additives, processing aids, antioxidants, curing agents, accelerators, etc. Elastomers, being a dominant part of stopper composition, play an important role in cleanliness. Any additive, residual curing agent, antioxidant or other impurities present in the elastomer can potentially become undesirable extractables and leachables. Furthermore, the choice of elastomer will inevitably be associated with certain curing systems that could be a major source of harmful extractables. The fact that bromobutyl can be effectively cured via low levels of sulfur-free and / or zinc-free curing systems is the major reason for it to become the number one choice worldwide for pharmaceutical stopper and seal applications today. In this presentation, we will discuss the type of curing systems required for a number of elastomers used in pharmaceutical packaging applications. This includes natural rubber (NR), synthetic isoprene rubber (IR), IIR, CIIR and BUR. We will discuss the clean and effective curing systems that could enable the use of BUR in pharmaceutical stopper and seal applications. Extractables of the BUR compounds cured with various clean curing systems will also be presented.
机译:由于其优异的弹性,渗透性和弹性性能,弹性体被在宽范围的药品包装使用。从历史上看在药品包装弹性体的主要用途已经从天然橡胶在初期到普通丁基(异丁烯异戊二烯橡胶,IIR),然后氯丁基(CIIR)和溴丁(BUR)聚合物转换。这些转变的主要驱动因素是清洁的改进。随着对患者的健康增加药物杂质的影响的认识,越来越紧法规正在实施。例如,近年来提取和受教组分的含量已成为药品瓶塞是合格的一个重要参数。的某些杂质的存在也可以停用的活性成分或在某些药物引起的变化,并且因此止动器的药物的相容性是很重要的。药品瓶塞的清洁度是由制造工艺和每种成分的化合物中的洁净度确定的,即,弹性体,填料,添加剂,加工助剂,抗氧化剂,固化剂,促进剂,弹性体等,作为止动器组合物的主要部分,起到清洁的重要作用。任何添加剂,残留的固化剂,抗氧化剂或其它杂质存在于弹性体可潜在地不希望成为可提取物和沥滤物。此外,弹性体的选择将不可避免地被与某些固化系统,可能是有害的可提取物的主要来源相关联。该溴化丁基橡胶可以通过和/或无锌无硫的固化体系的低的水平可有效地固化的事实是它成为用于药物塞子和密封应用今天的第一选择全世界的主要原因。在本次讲座中,我们将讨论固化了一些在药品包装应用中使用的弹性体所需的系统类型。这包括天然橡胶(NR),合成异戊二烯橡胶(IR),IIR,CIIR和BUR。我们将讨论清洁和有效硫化体系,可以使医药塞子和密封应用中使用BUR的。与各种清洁固化体系固化的BUR化合物的提取物也将被呈现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号